EXL
Elixinol
🇦🇺 ASX
🛍️ CONSUMER
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-18.20%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
9
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-08. The firm is engaged in marketing and selling hemp derived and other plant-based nutraceuticals, skincare and food products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of complementary products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp Foods Australia, Mt Elephant and Field Day and are sold through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products based in Colorado, United States. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.
📈 Performance
Price History
-95.37%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.04
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EXL
9
📊 Total Capital Earnings
$2K
🔃 Average investment frequency
23 weeks
💵 Average investment amount
$357
⏰ Last time a customer invested in EXL
133 days
EXL investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
20%
50k - 100k
60%
Less than 50k
20%
👶 Age of investors
18 - 25
26 - 34
33%
35 - 90
67%
🙋 Legal gender of investors
Female
44%
Male
56%
Pearlers who invest in EXL also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.62%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.79%
📊 Share price
$68.90 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
IMU
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
4.67%
📊 Share price
$0.04 AUD
🧬 BIOTECHNOLOGY
Want more shares? Try these...
Experience Co. Ltd. is an adventure tourism company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-03-27. The principal activities of the Company are the provision of adventure tourism and leisure experiences. The Company’s segments include Skydiving, Adventure Experiences, and Corporate. The Skydiving segment comprises tandem skydive and related products, with ancillary aircraft maintenance activities. The Adventure Experiences segment comprises tours to the Great Barrier Reef and Daintree region, high rope and zipline aerial activities, and nature-based walking and lodge-experiences. Its experiences include skydiving, island day trips, reef tours, rainforest tours, multi-day experiences and tree ropes and ziplining. Its island brands include Fitzroy Island Adventures, Big Cat Green Island Reef Cruises, and Calypso Low Isles. Its multi-day experiences include The Maria Island Walk, The Arkaba Walk, Arkaba Conservancy, and Bamurru Plains. Its reef tour brands include Dreamtime Dive & Snorkel, Reef Magic, and others.
🙌 Performance (5Yr p.a)
-8.92%
📊 Share price
$0.13 AUD
🏨 HOTELS, RESTAURANTS & LEISURE
Energy World Corp. Ltd. operates as an integrated energy company, which engages in the production and sale of power and natural gas. The company is headquartered in Sydney, New South Wales. The firm operates through four segments: Oil and Gas in Australia, Oil and Gas in Indonesia, Power in Indonesia, and Project Development. The Company’s operations are in three countries: Philippines, Indonesia, and Australia. Its Philippines operations is engaged in the development of the LNG Hub terminal in the Philippines and development of 650 megawatts (MW) combined cycle gas fired power plant. Its Indonesia operations include a 315 MW Senkang combined cycle gas fired power plant, development of a 2 million tons per annum (mtpa) LNG liquification plant and Sengkang gas field. Its Australia operations include ownership interests in various gas fields, development of a 56,000 tpa LNG Liquification plant, an 8 MW Alice Springs power plant, and Alice Springs LNG plant.
🙌 Performance (5Yr p.a)
-15.14%
📊 Share price
$0.02 AUD
🔋 UTILITIES
EX20.AX was created on 2016-10-05 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. EX20.AX aims to track the performance of an index (before fees and expenses) comprising the 180 largest stocks listed on the ASX, after excluding the 20 largest, based on their market capitalisation.
🙌 Performance (5Yr p.a)
2.24%
📊 Share price
$21.71 AUD
⛳️ DIVERSIFIED